Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 0.5945M
March 31, 2026 0.1944M
December 31, 2025 -1.045M
September 30, 2025 -0.1393M
June 30, 2025 -0.2253M
March 31, 2025 0.0578M
December 31, 2024 0.1574M
September 30, 2024 0.5364M
June 30, 2024 -0.0592M
March 31, 2024 0.4262M
December 31, 2023 -2.671M
September 30, 2023 0.3707M
June 30, 2023 -0.0929M
March 31, 2023 -0.1483M
December 31, 2022 -2.534M
September 30, 2022 -2.117M
June 30, 2022 -10.89M
March 31, 2022 0.7912M
December 31, 2021 -5.299M
September 30, 2021 -10.41M
June 30, 2021 8.820M
March 31, 2021 2.411M
December 31, 2020 -13.75M
September 30, 2020 0.3142M
June 30, 2020 9.147M
Date Value
March 31, 2020 -91.65M
December 31, 2019 96.48M
September 30, 2019 -2.674M
June 30, 2019 -14.32M
March 31, 2019 6.778M
December 31, 2018 -21.77M
September 30, 2018 -21.82M
June 30, 2018 -19.45M
March 31, 2018 -134.48M
December 31, 2017 -145.05M
September 30, 2017 -1.023M
June 30, 2017 -2.243M
March 31, 2017 -6.877M
December 31, 2016 -0.186M
September 30, 2016 -5.844M
June 30, 2016 -3.809M
March 31, 2016 -9.847M
December 31, 2015 25.56M
September 30, 2015 -6.118M
June 30, 2015 -5.806M
March 31, 2015 -0.1906M
December 31, 2014 3.519M
September 30, 2014 -0.6403M
June 30, 2014 -7.604M
March 31, 2014 -2.367M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
ZeroStack Corp. 1.384M
Interpace Biosciences, Inc. 0.098M
PD-Rx Pharmaceuticals, Inc. --
Acro Biomedical Co. Ltd. -0.0105M
Stella Diagnostics, Inc. -0.9776M